Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
CSPC Innovation Pharm
ISIN CNE100003K04
|WKN A3E3S9
Market cap (in EUR)
6,885 m
Country
China
Sector
Non-Energy Materials
Dividend yield
0.05%
Overview
Description
CSPC Innovation Pharmaceutical Co., Ltd. engages in the research and development, production and sale of biopharmaceuticals. It operates through the Functional Ingredients and Nutritional Products and Biopharmaceuticals segments. The Functional Ingredients and Nutritional Products segment produces and sells functional food products including caffeine products, anhydrous glucose, acarbose, and vitamin C buccal tablets. The Biopharmaceuticals segment covers research and development, production, and sale of pharmaceutical products and license fee income. The company was founded on April 5, 2006 and is headquartered in Shijiazhuang, China.
Non-Energy Materials Chemical, Plastic and Rubber Materials Specialty and Performance Chemicals China
Financials
Key metrics
| Market capitalisation, EUR | 6,885 m |
| EPS, EUR | -0.01 |
| P/B ratio | 15.1 |
| P/E ratio | 1,190.7 |
| Dividend yield | 0.05% |
Income statement (2024)
| Revenue, EUR | 253 m |
| Net income, EUR | 7 m |
| Profit margin | 2.73% |
What ETF is CSPC Innovation Pharm in?
There are 11 ETFs which contain CSPC Innovation Pharm. All of these ETFs are listed in the table below. The ETF with the largest weighting of CSPC Innovation Pharm is the iShares MSCI Emerging Markets Islamic UCITS ETF.
Latest articles
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.